10-K: Amesite Pivots to Healthcare AI, Faces Going Concern Doubt

Amesite Inc. shifts its core business to AI-powered healthcare solutions with NurseMagic, reporting reduced net losses but facing substantial doubt about its ability to continue as a going concern.

Summary

• Completed a strategic pivot in fiscal 2025 from an education-centric model to AI-powered solutions for the healthcare sector, focusing on the post-acute care market.
• Operates through two product lines under the NurseMagic brand: a B2C (direct-to-practitioner) app and a B2B (enterprise) platform, designed to address operational, compliance, and efficiency challenges.
• Reported a net loss of approximately $3,617,000 for the fiscal year ended June 30, 2025, a reduction from $4,403,000 in fiscal year 2024.
• Revenue for fiscal year 2025 was $110,459, a decrease from $166,881 in fiscal year 2024, though the NurseMagic customer base expanded.
• Management and auditors have raised substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flows from operations.
• Cash balance as of June 30, 2025, totaled $2,433,418.
• Successfully raised approximately $3.08 million in net cash proceeds from a public offering on January 8, 2025.
• Incurred an impairment loss of $90,869 in FY2025 related to capitalized software due to discontinuing development of the higher education/professional learning app.
• One customer accounted for 41% of revenues in FY2025, indicating a concentration risk.

Sentiment

Score: 3

Explanation: While the company has made a strategic pivot to a high-growth sector and reduced its net loss, the explicit 'substantial doubt about our ability to continue as a going concern' statement, coupled with declining revenue and reliance on future, uncertain capital raises, indicates significant financial instability and high risk. The positive aspects are heavily outweighed by the fundamental challenges to its continued operations.

Positives

• Successfully completed a strategic pivot to the high-growth healthcare sector with AI-powered solutions, specifically targeting the underserved post-acute care market.
• NurseMagic app and platform are gaining traction with both B2C individual practitioners and B2B enterprise customers, demonstrating market relevance and commercial fit.
• Reduced net loss in fiscal year 2025 to $3,617,000 from $4,403,000 in fiscal year 2024, primarily due to significant cost savings in general and administrative, technology and content development, and sales and marketing expenses.
• Achieved HIPAA compliance for NurseMagic in April 2025, enhancing credibility and facilitating broader adoption in the healthcare industry.
• Introduced NurseMagic Teams+ and NurseMagic Enterprise in April and July 2025, respectively, expanding product offerings and targeting larger-scale customers with advanced features like EMR integration.
• Maintains strong fiscal discipline, managing costs and prioritizing efficient resource allocation to support responsible growth.
• Secured 14 U.S. patents (11 utility, 3 design) and has one pending U.S. patent application, protecting its AI platform and other technologies.
• Cultivated a growing online community exceeding 37,000 followers for NurseMagic, which aids in brand building and word-of-mouth growth.

Negatives

• Substantial doubt exists about the ability to continue as a going concern due to recurring net losses and negative cash flows from operating activities since inception.
• Reported a net loss of $3,617,086 for the fiscal year ended June 30, 2025, and a cumulative net loss of $41,450,587 since incorporation.
• Revenue decreased to $110,459 in fiscal year 2025 from $166,881 in fiscal year 2024, indicating a short-term reduction in overall revenue despite the strategic pivot.
• Management believes it may not have sufficient cash and cash equivalents to maintain planned operations for the next twelve months.
• Reliance on future financing transactions, such as common stock offerings, which are subject to market conditions and are not deemed probable, creating uncertainty about future funding.
• Faces intense competition in the healthcare software market from established platforms, agile mid-market firms, and numerous AI-first entrants, many of whom possess greater resources and larger installed bases.
• Highly dependent on the services of certain key management personnel, employees, advisors, and consultants, with no key person life insurance maintained on any employees except the Chief Executive Officer.
• Incurred an impairment loss of $90,869 in fiscal year 2025 related to capitalized software due to the decision to discontinue development of the higher education/professional learning app.
• One customer accounted for 41% of revenues in fiscal year 2025, indicating a significant customer concentration risk.

Risks

• Compliance and Regulatory Risks: Failure to maintain compliance with applicable laws such as HIPAA, the HITECH Act, CMS rules, and emerging AI-focused regulations (including transparency, bias, and cybersecurity standards) could expose the company to significant penalties, legal action, or restrictions on its business.
• Adoption, Market Penetration, and Growth Risks: The healthcare software industry is intensely competitive, and there is no guarantee that healthcare organizations and individual practitioners will continue to adopt the platform, perceive sufficient differentiation or ROI, or retain their subscriptions over time.
• Technology, Data, and Operational Risks: Reliance on the robustness, accuracy, and security of proprietary technologies; bugs, performance issues, or unexpected behavior in algorithms could disrupt customer operations, erode trust, or expose sensitive data. Persistent cybersecurity and data protection risks are inherent in managing health-related and personal information.
• Financial and Business Model Risks: The company has not yet established a stable, recurring revenue base sufficient to cover ongoing expenses and has incurred net losses in recent fiscal years. Failure to achieve broad adoption or realize operational efficiencies could force scaling back investment.
• General and Macroeconomic Risks: General economic downturns, reductions in healthcare or IT spending, changes in regulatory or reimbursement environments, or disruptions to the workforce or supply chain could adversely impact sales, revenue, or execution capacity.
• Going Concern Risk: There is substantial doubt about the company's ability to continue as a going concern due to recurring losses from operations and negative cash flows, and the uncertainty of obtaining additional funding.
• Dependence on Key Personnel: The company is dependent on the services of certain key management personnel, employees, advisors, and consultants, and the loss of one or more of these individuals could hamper business operations.
• Operational and Financial Instability: Operating results are highly susceptible to fluctuations due to numerous factors beyond control, and the cost and complexity of developing tailored features and ensuring data security require substantial investment.
• Intellectual Property Risks: The company may not be able to protect its intellectual property rights, which could erode its competitive position.
• Acquisition Risks: Future acquisitions could disrupt the business, cause dilution to stockholders, incur debt and liabilities, and pose integration challenges.
• Security Breach Risks: If security measures or those of future business partners are breached or fail, resulting in unauthorized disclosure of data, the company could lose customers, harm its reputation, and face protracted and costly lawsuits.
• Common Stock Market Risks: An active trading market for common stock may not be sustained, and future sales and issuances of securities could result in additional dilution of percentage ownership.
• Nasdaq Delisting Risk: The Nasdaq Capital Market may delist the company's securities from trading, which could limit investors' ability to make transactions and subject the company to additional trading restrictions.
• Internal Control Over Financial Reporting Risks: Failure to develop and maintain proper and effective internal controls over financial reporting could adversely affect investor confidence and the value of common stock.
• Public Company Costs: Financial reporting obligations as a public company are expensive and time-consuming, requiring management to devote substantial time to compliance matters.
• Concentrated Stock Ownership: Principal stockholders and management own a significant percentage of common stock (approximately 29%), enabling them to exert significant control over matters subject to stockholder approval.
• Exclusive Forum Provisions: The company's certificate of incorporation provides that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for substantially all disputes, which could limit stockholders' ability to obtain a favorable judicial forum.
• Anti-Takeover Provisions: Certain provisions of the certificate of incorporation and Delaware law make it more difficult for a third party to acquire the company, even if such a transaction were in stockholders' interest.

Future Outlook

Management believes that AI-powered programs, priced affordably, will supplant other academic products in the mid to long term. The company has focused all new development work on delivering AI tools to markets hungry for increased capability that immediately impacts both performance and bottom line. NurseMagic Enterprise was introduced in July 2025, designed for larger-scale customers with EMR integration, tailored compliance, billing documentation, and patient census-based pricing. The company expects to continue to incur net losses and use cash in its operations in the foreseeable future.

Management Comments

• "We believe that we have a pathway to deliver AI solutions impactfully, quickly, and compliantly across this expansive, underserved segment."
• "Our disciplined, evidence-based approach in both segments supports Amesite's reputation as a partner that delivers real solutions to pressing business challenges, helping drive strong adoption, build reference customers, and sustain healthy growth, even in complex, compliance-intensive markets."
• "We believe that we have consistently endeavored to provide strong fiscal discipline, launching and scaling innovative products while managing costs and prioritizing efficient resource allocation."
• "We believe this disciplined approach strengthens our potential to grow responsibly, and ultimately, profitably."
• "We have strongly pivoted to grow our customer base while reducing risk and losses, resulting in a larger client base, a short-term reduction in overall revenue and a dramatic reduction in cash burn."
• "We continue to believe that AI-powered programs, priced affordably, will supplant other academic products in the mid to long term, but have defocused on securing academic customers, and are now offering solutions for the healthcare industry."
• "We have focused all new development work on delivering AI tools to markets hungry for increased capability that immediately impacts both their performance and their bottom line."
• "Our mission is to empower people with AI tools. We believe that supporting our team with a wonderful environment supports and powers us to accomplish our goals."

Industry Context

The company operates in the highly competitive healthcare software market, which includes established Electronic Medical Record (EMR) or Electronic Health Record (EHR) firms, mid-market and specialized vendors, AI-first entrants, and niche clinical tools vendors. Amesite aims to differentiate NurseMagic by combining rapid deployment, practitioner-driven design, and robust compliance for post-acute care, positioning itself at the intersection of these segments. The industry is characterized by extensive regulatory oversight at both federal and state levels (e.g., HIPAA, HITECH Act, CMS rules) and rapid technological change, particularly in AI, demanding continuous innovation and strict adherence to standards for patient privacy and data security.

Comparison to Industry Standards

• No specific comparable companies, projects, or results are listed in the filing for direct comparison to global benchmarks or industry standards.

Management Changes

Corporate Governance

Legal Proceedings

• Not currently a party to or aware of any legal proceedings that are believed to have, individually or in aggregate, a material adverse effect on the business, financial condition, or results of operations.

Related Party Transactions

• The CEO and two members of the Board of Directors purchased an aggregate of 419,999 common stock shares at a price of $3.00 per share for total proceeds to the company of $1,259,997 in the January 8, 2025 public offering.
• The Board of Directors received stock-based compensation for the fiscal years ended June 30, 2025, and 2024.
• One director received cash payments totaling $27,750 for the fiscal year ended June 30, 2025, and $55,500 for the fiscal year ended June 30, 2024.

Stakeholder Impact

• Shareholders: Face potential for substantial dilution from future equity issuances, as the company will need additional funding. Returns are limited to the increase in share price as no cash dividends are anticipated. The significant concentration of stock ownership by principal stockholders and management (29%) allows them to exert significant control. There is a risk of delisting from Nasdaq, which could limit market liquidity and analyst coverage.
• Employees: The company's future success is highly dependent on attracting, retaining, and motivating key management and technical personnel. Competition for qualified employees is intense, and future acquisitions could cause uncertainty and lead to departures of key individuals.
• Customers (Healthcare Organizations & Practitioners): NurseMagic aims to provide tools to reduce documentation time, simplify communication, and support daily workflow, offering measurable improvements in staff efficiency and retention. Risks include potential lack of adoption, integration challenges, and negative perceptions of AI in clinical environments.
• Creditors: The 'substantial doubt about our ability to continue as a going concern' raises significant concerns for creditors regarding the company's ability to meet its future obligations.
• Suppliers/Partners: The company relies on third-party designers, suppliers, and partners to provide and maintain its Site, making it vulnerable to disruptions or failures in these relationships.

Next Steps

• Continue to refine and improve sales and marketing strategy and tactics for NurseMagic to maximize reach and value.
• Ongoing investment in research, data infrastructure, and security practices to maintain the rapid pace of AI innovation.
• Monitor regulatory developments and proactively ensure full compliance with evolving healthcare laws and regulations for current and future market expansions.
• Develop and complete technology platforms, continuing to capitalize significant software development costs.
• Generate cash by completing financing transactions, which may include offerings of common stock, to address liquidity concerns.
• File the definitive proxy statement for the next Annual Meeting of Stockholders with the SEC within 120 days after the end of the fiscal year.

Key Dates

Recommendation

The company faces severe financial challenges, explicitly stating 'substantial doubt about our ability to continue as a going concern' in both management's discussion and the auditor's report. This fundamental issue, combined with recurring net losses, declining revenue, and a stated reliance on uncertain future financing, indicates a high risk of further financial deterioration or business failure. While the strategic pivot to healthcare AI and cost savings are noted, they are insufficient to offset the immediate and critical liquidity and profitability concerns. A seasoned investor would prioritize capital preservation and exit positions given the significant going concern risk.

Keywords

AI-powered solutions, healthcare technology, NurseMagic, post-acute care, SaaS, digital health, nursing documentation, workflow automation, HIPAA compliance, SEC 10-K, financial reporting, going concern, technology company, B2B healthcare, B2C healthcare, AI in healthcare